scispace - formally typeset
M

Michael A. Preece

Researcher at University College London

Publications -  176
Citations -  16221

Michael A. Preece is an academic researcher from University College London. The author has contributed to research in topics: Genomic imprinting & Chromosome 7 (human). The author has an hindex of 60, co-authored 176 publications receiving 15685 citations. Previous affiliations of Michael A. Preece include Queen's University & Great Ormond Street Hospital.

Papers
More filters
Journal ArticleDOI

Body mass index reference curves for the UK, 1990.

TL;DR: Centile curves for BMI in British children are presented, from birth to 23 years, based on the same large representative sample as used to update the stature and weight references, derived using Cole's LMS method.
Journal ArticleDOI

Association between postnatal catch-up growth and obesity in childhood: prospective cohort study.

TL;DR: In this contemporary well nourished cohort, catch-up growth was predicted by factors relating to intrauterine restraint of fetal growth, and children who showed catch- up growth between zero and two years were fatter and had more central fat distribution at five years than other children.
Journal ArticleDOI

Cross sectional stature and weight reference curves for the UK, 1990.

TL;DR: Using current data from seven sources new reference curves have been estimated from birth to 20 years for children in 1990 and it is proposed that the curves presented here should be adopted as the new UK reference curves.
Journal ArticleDOI

British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood.

TL;DR: To update the British growth reference, anthropometric data for weight, height, body mass index and head circumference from 17 distinct surveys representative of England, Scotland and Wales were analysed by maximum penalized likelihood using the LMS method.
Journal ArticleDOI

Iatrogenic Creutzfeldt-Jakob disease at the millennium.

TL;DR: Knowledge about potential high-risk sources of contamination gained during the last quarter century, and the implementation of methods to circumvent them, should minimize the potential for iatrogenic contributions to the current spectrum of CJD.